Digital Guide: Tyrosine Kinase Inhibitors (TKIs) for CML

An in-depth look at how tyrosine kinase inhibitors (TKIs), a type of targeted therapy, are used to treat chronic myeloid leukemia (CML).

This guide includes explanations from top hematologists about how tyrosine kinase inhibitors (TKIs) are used to treat chronic myeloid leukemia (CML).

TKIs are targeted therapy drugs that block the effects of BCR:ABL1 (the abnormal protein found in people with CML). In this guide, the featured doctors explain how they are taken, why they have been so successful in treating people with CML, and what side effects may occur.

Dr. Javier Pinilla Moffitt Cancer Center

Your Digital Guide begins below: 4 Chapters / 4 Video Segments


Get SurvivorNet in Your Inbox

Our newsletter – vital information, hope, and healing, delivered weekly.

Never want to see this again? Click here to dismiss this module permanently.

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.